162 GENES FOUNDi
Show / hide columns Aggregate: Custom reports Download: XML | RDF | TSV | JSON | Custom TSV/JSON Page of 4 | next »
Genei
Gene descriptioni x
Evidencei x
Tissuei
Braini
Single celli
Subcelli
Canceri
Bloodi
Cell linei
Struct & Inti
Prognostic p-valuei x
TRA2BTransformer 2 beta homolog
Kidney Renal Clear Cell Carcinoma (TCGA): 2.01e-6
Prostate Adenocarcinoma (TCGA): 5.40e-6
Liver Hepatocellular Carcinoma (TCGA): 1.12e-4
Liver Hepatocellular Carcinoma (validation): 1.93e-4
Lung Adenocarcinoma (validation): 9.69e-4
NCBP2Nuclear cap binding protein subunit 2
Liver Hepatocellular Carcinoma (TCGA): 4.99e-8
Prostate Adenocarcinoma (TCGA): 6.86e-6
Breast Invasive Carcinoma (TCGA): 1.41e-4
Pancreatic Adenocarcinoma (TCGA): 1.86e-4
Lung Adenocarcinoma (TCGA): 5.07e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 5.24e-4
Liver Hepatocellular Carcinoma (validation): 8.45e-4
HELLSHelicase, lymphoid specific
Kidney Renal Papillary Cell Carcinoma (TCGA): 2.20e-5
Liver Hepatocellular Carcinoma (TCGA): 2.40e-5
Prostate Adenocarcinoma (TCGA): 5.53e-5
Liver Hepatocellular Carcinoma (validation): 1.03e-4
Lung Adenocarcinoma (TCGA): 2.37e-4
Lung Adenocarcinoma (validation): 9.36e-4
ZNF330Zinc finger protein 330
Kidney Renal Clear Cell Carcinoma (TCGA): 1.22e-7
Prostate Adenocarcinoma (TCGA): 8.62e-5
Kidney Renal Clear Cell Carcinoma (validation): 7.82e-4
ZNF440Zinc finger protein 440
Prostate Adenocarcinoma (TCGA): 1.03e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 4.29e-4
Rectum Adenocarcinoma (TCGA): 4.64e-4
Kidney Renal Clear Cell Carcinoma (validation): 5.81e-4
Bladder Urothelial Carcinoma (TCGA): 5.97e-4
ZNF773Zinc finger protein 773
Kidney Renal Clear Cell Carcinoma (TCGA): 6.61e-6
Kidney Renal Clear Cell Carcinoma (validation): 2.61e-5
Prostate Adenocarcinoma (TCGA): 2.30e-4
NOP16NOP16 nucleolar protein
Kidney Chromophobe (TCGA): 9.23e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.59e-4
Liver Hepatocellular Carcinoma (validation): 2.13e-4
Prostate Adenocarcinoma (TCGA): 2.56e-4
Liver Hepatocellular Carcinoma (TCGA): 4.16e-4
Lung Adenocarcinoma (validation): 7.50e-4
Lung Adenocarcinoma (TCGA): 7.89e-4
POLG2DNA polymerase gamma 2, accessory subunit
Liver Hepatocellular Carcinoma (TCGA): 3.99e-5
Prostate Adenocarcinoma (TCGA): 2.75e-4
Liver Hepatocellular Carcinoma (validation): 6.63e-4
SYNJ1Synaptojanin 1
Prostate Adenocarcinoma (TCGA): 2.82e-4
Head and Neck Squamous Cell Carcinoma (TCGA): 5.30e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 5.66e-4
Kidney Renal Clear Cell Carcinoma (validation): 7.11e-4
ZC3H15Zinc finger CCCH-type containing 15
Liver Hepatocellular Carcinoma (validation): 3.16e-5
Liver Hepatocellular Carcinoma (TCGA): 4.26e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 6.78e-5
Lung Adenocarcinoma (TCGA): 1.18e-4
Prostate Adenocarcinoma (TCGA): 3.00e-4
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 6.23e-4
SAFB2Scaffold attachment factor B2
Kidney Renal Clear Cell Carcinoma (validation): 1.44e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 2.95e-5
Pancreatic Adenocarcinoma (TCGA): 2.30e-4
Prostate Adenocarcinoma (TCGA): 3.68e-4
Liver Hepatocellular Carcinoma (TCGA): 6.74e-4
PNRC2Proline rich nuclear receptor coactivator 2
Kidney Renal Clear Cell Carcinoma (TCGA): 1.90e-6
Kidney Renal Clear Cell Carcinoma (validation): 7.25e-5
Liver Hepatocellular Carcinoma (TCGA): 1.10e-4
Prostate Adenocarcinoma (TCGA): 6.93e-4
Liver Hepatocellular Carcinoma (validation): 8.93e-4
FXR1FMR1 autosomal homolog 1
Liver Hepatocellular Carcinoma (TCGA): 1.27e-5
Lung Adenocarcinoma (TCGA): 4.31e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 6.48e-5
Liver Hepatocellular Carcinoma (validation): 6.83e-5
Lung Adenocarcinoma (validation): 5.41e-4
Pancreatic Adenocarcinoma (TCGA): 5.46e-4
Prostate Adenocarcinoma (TCGA): 7.32e-4
Head and Neck Squamous Cell Carcinoma (TCGA): 7.56e-4
Colon Adenocarcinoma (validation): 8.67e-4
LLGL2LLGL scribble cell polarity complex component 2
Kidney Renal Clear Cell Carcinoma (TCGA): 1.56e-11
Kidney Renal Clear Cell Carcinoma (validation): 1.66e-5
Prostate Adenocarcinoma (TCGA): 8.32e-4
BTG2BTG anti-proliferation factor 2
Bladder Urothelial Carcinoma (TCGA): 2.26e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 6.47e-5
Lung Adenocarcinoma (TCGA): 7.16e-5
Prostate Adenocarcinoma (TCGA): 8.54e-4
Kidney Renal Clear Cell Carcinoma (validation): 8.62e-4
PPM1DProtein phosphatase, Mg2+/Mn2+ dependent 1D
Kidney Renal Clear Cell Carcinoma (TCGA): 8.90e-5
Kidney Renal Clear Cell Carcinoma (validation): 5.04e-4
Pancreatic Adenocarcinoma (TCGA): 7.61e-4
Prostate Adenocarcinoma (TCGA): 8.87e-4
NUP107Nucleoporin 107
Liver Hepatocellular Carcinoma (TCGA): 7.02e-7
Lung Adenocarcinoma (TCGA): 5.72e-4
Liver Hepatocellular Carcinoma (validation): 6.10e-4
Prostate Adenocarcinoma (TCGA): 9.08e-4
EIF2S2Eukaryotic translation initiation factor 2 subunit beta
Liver Hepatocellular Carcinoma (TCGA): 2.21e-7
Liver Hepatocellular Carcinoma (validation): 5.08e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 5.23e-4
Lung Adenocarcinoma (TCGA): 5.65e-4
Head and Neck Squamous Cell Carcinoma (TCGA): 7.30e-4
Prostate Adenocarcinoma (TCGA): 9.39e-4
GAS2Growth arrest specific 2
Kidney Renal Clear Cell Carcinoma (validation): 8.42e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 8.89e-4
SRSF4Serine and arginine rich splicing factor 4
Prostate Adenocarcinoma (TCGA): 1.22e-5
Liver Hepatocellular Carcinoma (TCGA): 2.15e-4
DUSP7Dual specificity phosphatase 7
Glioblastoma Multiforme (validation): 7.04e-7
Prostate Adenocarcinoma (TCGA): 1.29e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 4.48e-5
YJU2BYJU2 splicing factor homolog B
Prostate Adenocarcinoma (TCGA): 1.86e-5
Head and Neck Squamous Cell Carcinoma (TCGA): 7.65e-4
NCBP1Nuclear cap binding protein subunit 1
Prostate Adenocarcinoma (TCGA): 2.30e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 9.06e-5
PCDHA4Protocadherin alpha 4
Prostate Adenocarcinoma (TCGA): 2.69e-5
BMP8BBone morphogenetic protein 8b
Prostate Adenocarcinoma (TCGA): 3.03e-5
WDR27WD repeat domain 27
Prostate Adenocarcinoma (TCGA): 3.35e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 1.62e-4
CDK2Cyclin dependent kinase 2
Prostate Adenocarcinoma (TCGA): 4.23e-5
Liver Hepatocellular Carcinoma (TCGA): 1.12e-4
Liver Hepatocellular Carcinoma (validation): 1.37e-4
Lung Adenocarcinoma (TCGA): 2.36e-4
Kidney Chromophobe (TCGA): 6.80e-4
ARL10ADP ribosylation factor like GTPase 10
Prostate Adenocarcinoma (TCGA): 4.81e-5
Ovary Serous Cystadenocarcinoma (validation): 1.47e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 7.89e-4
MRPL16Mitochondrial ribosomal protein L16
Prostate Adenocarcinoma (TCGA): 5.13e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 5.81e-5
Pancreatic Adenocarcinoma (TCGA): 1.03e-4
Lung Adenocarcinoma (TCGA): 1.22e-4
Lung Adenocarcinoma (validation): 2.65e-4
RAPGEFL1Rap guanine nucleotide exchange factor like 1
Kidney Renal Clear Cell Carcinoma (TCGA): 4.69e-9
Prostate Adenocarcinoma (TCGA): 5.28e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 6.09e-4
WDR53WD repeat domain 53
Liver Hepatocellular Carcinoma (TCGA): 1.02e-7
Prostate Adenocarcinoma (TCGA): 5.86e-5
FBXO45F-box protein 45
Liver Hepatocellular Carcinoma (validation): 1.94e-7
Lung Adenocarcinoma (TCGA): 1.73e-5
Prostate Adenocarcinoma (TCGA): 6.03e-5
Pancreatic Adenocarcinoma (TCGA): 2.96e-4
Kidney Chromophobe (TCGA): 3.24e-4
Liver Hepatocellular Carcinoma (TCGA): 3.71e-4
Lung Adenocarcinoma (validation): 6.88e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 9.13e-4
MTRFRMitochondrial translation release factor in rescue
Liver Hepatocellular Carcinoma (TCGA): 1.05e-7
Prostate Adenocarcinoma (TCGA): 6.17e-5
Glioblastoma Multiforme (validation): 3.20e-4
TGDSTDP-glucose 4,6-dehydratase
Kidney Renal Clear Cell Carcinoma (TCGA): 7.93e-5
Prostate Adenocarcinoma (TCGA): 8.91e-5
CFC1Cripto, FRL-1, cryptic family 1
Prostate Adenocarcinoma (TCGA): 8.97e-5
INTS6LIntegrator complex subunit 6 like
Prostate Adenocarcinoma (TCGA): 9.40e-5
Ovary Serous Cystadenocarcinoma (validation): 1.26e-4
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 8.38e-4
MORN5MORN repeat containing 5
Prostate Adenocarcinoma (TCGA): 1.04e-4
MAP6D1MAP6 domain containing 1
Prostate Adenocarcinoma (TCGA): 1.11e-4
Bladder Urothelial Carcinoma (TCGA): 3.70e-4
MMDMonocyte to macrophage differentiation associated
Liver Hepatocellular Carcinoma (validation): 3.23e-6
Kidney Renal Papillary Cell Carcinoma (TCGA): 3.39e-6
Liver Hepatocellular Carcinoma (TCGA): 4.88e-5
Prostate Adenocarcinoma (TCGA): 1.17e-4
Pancreatic Adenocarcinoma (validation): 4.82e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 6.86e-4
TIMM9Translocase of inner mitochondrial membrane 9
Liver Hepatocellular Carcinoma (TCGA): 6.42e-7
Kidney Renal Clear Cell Carcinoma (TCGA): 7.66e-6
Liver Hepatocellular Carcinoma (validation): 3.82e-5
Lung Adenocarcinoma (TCGA): 6.12e-5
Prostate Adenocarcinoma (TCGA): 1.30e-4
Head and Neck Squamous Cell Carcinoma (TCGA): 1.57e-4
Rectum Adenocarcinoma (validation): 6.53e-4
MRPL40Mitochondrial ribosomal protein L40
Prostate Adenocarcinoma (TCGA): 1.31e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.46e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 7.06e-4
Glioblastoma Multiforme (validation): 9.19e-4
SLC27A3Solute carrier family 27 member 3
Pancreatic Adenocarcinoma (validation): 5.73e-5
Glioblastoma Multiforme (validation): 7.76e-5
Ovary Serous Cystadenocarcinoma (validation): 1.29e-4
Prostate Adenocarcinoma (TCGA): 1.38e-4
C4orf19Chromosome 4 open reading frame 19
Kidney Renal Clear Cell Carcinoma (TCGA): 1.62e-9
Pancreatic Adenocarcinoma (validation): 1.25e-4
Prostate Adenocarcinoma (TCGA): 1.48e-4
Colon Adenocarcinoma (TCGA): 6.83e-4
KCNC3Potassium voltage-gated channel subfamily C member 3
Prostate Adenocarcinoma (TCGA): 1.50e-4
Breast Invasive Carcinoma (validation): 1.67e-4
DVL3Dishevelled segment polarity protein 3
Prostate Adenocarcinoma (TCGA): 1.54e-4
Lung Squamous Cell Carcinoma (validation): 3.86e-4
Liver Hepatocellular Carcinoma (TCGA): 7.29e-4
HILPDAHypoxia inducible lipid droplet associated
Liver Hepatocellular Carcinoma (TCGA): 9.58e-12
Kidney Chromophobe (TCGA): 8.88e-7
Prostate Adenocarcinoma (TCGA): 1.55e-4
Lung Adenocarcinoma (validation): 1.66e-4
SMC4Structural maintenance of chromosomes 4
Pancreatic Adenocarcinoma (TCGA): 5.21e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 3.35e-5
Prostate Adenocarcinoma (TCGA): 1.61e-4
TEX30Testis expressed 30
Prostate Adenocarcinoma (TCGA): 1.72e-4
Glioblastoma Multiforme (validation): 3.36e-4
Lung Adenocarcinoma (validation): 8.82e-4
NTNG2Netrin G2
Prostate Adenocarcinoma (TCGA): 1.79e-4
Rectum Adenocarcinoma (validation): 5.32e-4
Page of 4 | next »